Smith Patrick W
Visual SEC Form 4 history across 2 companies, 49 transactions and 8 filings.
Open-market buy performance
90-day forward return on this insider's open-market purchases
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Net value flow
Buys minus sells
Transaction texture
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| OCX | SMITH PATRICK W | 10% | other | 385k | $79.0M | J | — | — | 02/11/2025 | 02/07/2025 |
| OCX | SMITH PATRICK W | 10% | buy | 1.07M | $220M | P | — | 02/11/2025 | 02/07/2025 | |
| OCX | SMITH PATRICK W | 10% | buy | 25 | $5.05k | P | — | 02/04/2025 | 02/04/2025 | |
| OCX | SMITH PATRICK W | 10% | buy | 890 | $178k | P | — | 02/04/2025 | 01/31/2025 | |
| OCX | SMITH PATRICK W | 10% | buy | 318 | $63.9k | P | — | 01/31/2025 | 01/30/2025 | |
| OCX | SMITH PATRICK W | 10% | buy | 3.88k | $779k | P | — | 01/31/2025 | 01/29/2025 | |
| OCX | SMITH PATRICK W | 10% | buy | 10.2k | $2.21M | P | — | 01/15/2025 | 01/14/2025 | |
| OCX | SMITH PATRICK W | 10% | buy | 100 | $20.8k | P | — | 01/15/2025 | 01/14/2025 | |
| OCX | SMITH PATRICK W | 10% | buy | 5.66k | $1.17M | P | — | 01/15/2025 | 01/13/2025 |
Smith Patrick W Insider Activity FAQ
SEC Form 4 context
Who is Smith Patrick W?
Smith Patrick W is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001167028.
Which companies has Smith Patrick W reported transactions for?
AXON ENTERPRISE, INC., Oncocyte Corp
When was Smith Patrick W's latest insider buy?
buy at Oncocyte Corp on Feb 07, 2025 valued at $2,209,080.
When was Smith Patrick W's latest insider sale?
sale at AXON ENTERPRISE, INC. on Mar 09, 2026 valued at $54,826.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.